What is an Optogenetic system?
Optogenetics is a biological technique to control the activity of neurons or other cell types with light. In systems neuroscience, the ability to control the activity of a genetically defined set of neurons has been used to understand their contribution to decision making, learning, fear memory, mating and addiction.
What is Optogenetic stimulation?
Optogenetic stimulation is a genetic technique that enables scientists to activate or inhibit the activity of specific neuron populations using light.
How are Neurons engineered to express Opsins?
One method, popular because it allows for tight control over spatial localization of opsin expression, is through the use of viral vector targeting systems. Using this approach, an engineered virus containing an opsin gene driven by a specific promoter is injected into the brain region of interest.
What are DREADDs used for?
Among chemogenetic tools, designer receptors exclusively activated by designer drugs (DREADDs) are widely used and are referred to as a biological “lock-and-key” system for selective manipulation of cell activity through G-protein signaling pathways.
How optogenetics excite neurons?
The most commonly used ion channel for stimulation in optogenetics is Channelrhodopsin-2. Neurons are triggered in the same way (by moving ions from outside the cell to the inside). Once a certain number of positive ions have crossed the cell membrane, a threshold is reached which causes the neuron to fire.
What is Halorhodopsin used for?
Halorhodopsin, a chloride pump activated by yellow light, was the first optogenetic tool used for neuronal silencing (Zhang et al., 2007). Activation of halorhodopsin and its variants transports chloride (a monovalent anion) ions into the cell to directly hyperpolarize the membrane potential.
How are DREADDs expressed?
In brief, DREADDs involve the use of receptor proteins derived from targeted mutagenesis of endogenous G-protein coupled receptor DNA to yield synthetic receptors. These receptors are readily expressed in neuronal membranes, but lack an endogenous ligand to activate them.
How are DREADDs administered?
(A) The standard approach whereby DREADDs are expressed in a cell-type-specific manner (either virally or transgenically) and then activated by systemic administration of chemical actuator.